0.1 |
23/03/2020 |
1st draft by head of secondary care analytics |
0.2 |
23/03/2020 |
Inclusion of medication methodology by Prescribing, Medicines and Pharmacy Clinical lead |
0.3 |
23/03/2020 |
Review and amendments by Head of Data management |
0.4 |
23/03/2020 |
Review and amendments by Caldicott Guardian |
0.5 |
24/03/2020 |
Update by Head of Data management |
0.6 |
24/03/2020 |
Joint review by Head of Data management & Caldicott Guardian |
0.7 |
24/03/2020 |
Draft Proofing by Head of Analytics Primary Care & Head of Communications |
0.8 |
24/03/2020 |
Final review by Head of Data management & Caldicott Guardian |
0.9 |
24/03/2020 |
Sign off by Chief Medical Officer & Caldicott Guardian |
1.0 |
24/03/2020 |
First version of Supporting Information |
2.0 |
06/04/2020 |
Second version of supporting information |
2.1 |
15/04/2020 |
Inclusion of processing steps using GP weekly COVID-19 dataset |
2.2 |
15/04/2020 |
Review and amendments by Head of Data management |
2.3 |
16/04/2020 |
Review and amendments by Caldicott Guardian |
3.0 |
16/04/2020 |
Third version of Supporting Information |
3.1 |
17/04/2020 |
Code movement between CMO categories, plus inclusion of additions and subtractions logic |
3.2 |
17/04/2020 |
Review by Caldicott Guardian |
4.0 |
17/05/2020 |
Fourth version of Supporting Information |
4.1 |
05/05/2020 |
Review and amendment to date ranges by Head of Data management |
4.2 |
05/05/2020 |
Review by Caldicott Guardian |
6.0 |
07/05/2020 |
Sixth version of Supporting Information |
8.0 |
22/05/2020 |
Eighth version of Supporting Information |
9.0 |
1/08/2020 |
Detained Person's SPL introduced |
10.0 |
28/09/2020 |
RCPCH guidance implemented and other minor updates |
11.0 |
26/02/2021 |
Down Syndrome, CKD5 and COVID-19 Population Risk Assessment implementation with associated logic |
11.1 |
18/03/2021 |
Rule change for neoplasm of lung and radiotherapy (Table 2) |
12.0 |
29/11/2021 |
Various changes to reflect shielding closure |